Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Etanercept (Enbrel) as Sole Treatment for Grade I Acute Graft Versus Host Disease

NCT00726375 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.

NCT NCT00726375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00726375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Etanercept (Enbrel) as Sole Treatment for Grade I Acute Graft Versus Host Disease
Lead sponsor
University of Michigan Rogel Cancer Center
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2008
Completion date
September 30, 2014
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute graft versus host disease